https://www.clinicaltrialsarena.com/uncategorized/newsboehringer-completes-enrolment-of-two-phase-iii-studies-of-nintedanib/
Boehringer completes enrolment of two Phase III studies of nintedanib - Clinical Trials Arena
Sep 27, 2012 - Boehringer Ingelheim Pharmaceuticals has announced the completion of clinical trial enrolment in two Phase III studies evaluating the safety and efficacy of...
nintedanib clinical trialsof twophase iii